Members of the CIVP appointed
The Consiglio di Sorveglianza of the Human Technopole Foundation has appointed eight experts with proven professional qualifications to form the Standing Independent Evaluation Committee (CIVP).
In view of the upcoming opening of the National Facilities, the CIVP’s task will be to assess and approve the applications for access to the Facilities. During its first meetings, the CIVP will therefore elaborate the selection procedures for the access to the Facilities, including the criteria for the evaluation and selection of access requests, according to international best practices.
The members selected and appointed by the Consiglio di Sorveglianza of the HT Foundation, which also include the ex officio member Walter Ricciardi Chairman of Human Technopole’s Scientific Committee, are (in alphabetic order):
Professor Juha Kere, Professor of Molecular Genetics, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden
Professor Filippo Mancia, Professor of Physiology and Cellular Biophysics, Department of Physiology & Cellular Biophysics, Columbia University, New York, U.S.A.
Professor Samuele Marro, Associate Professor of Neuroscience and co-Director of the Stem Cell Engineering Core, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, U.S.A.
Dr. Jan Peychl, Senior Service Leader, Light Microscopy Facility, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
Professor Giampietro Schiavo, Professor of Neuroscience, Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, UK
Professor Maria Secrier, Associate Professor of Computational Cancer Biology, Genetics Institute, Department of Genetics, Evolution and Environment, University College London, UK
Professor Arianna Tucci, Associate Professor of Medical Genomics, Queen Mary University of London, UK
Dr. Virginie Uhlmann, Group Leader, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK and Director of the BioVisionCenter, University of Zurich, CH
The members of the SIEC were selected following the publication of a public notice for the pre-selection of candidates for the establishment of the Committee on 4 July 2023. The Consiglio di Sorveglianza of the HT Foundation received the list of pre-selected candidates from the Ministry of University and Research and the Ministry of Health.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.